1. CTNI-61. CLINICAL EFFICACY AND PREDICTIVE BIOMARKERS OF ONC201 IN H3K27M-MUTANT DIFFUSE MIDLINE GLIOMA. (14th November 2022) Authors: Kawakibi, Abed Rahman; Tarapore, Rohinton; Gardner, Sharon; Chi, Andrew; Kurz, Sylvia; Wen, Patrick Y; Arrillaga-Romany, Isabel; Batchelor, Tracy; Butowski, Nicholas; Sumrall, Ashley; Shonka, Nicole; Harrison, Rebecca; DeGroot, John; Mehta, Minesh; Odia, Yazmin; Hall, Matthew; Daghistani, Doured;... Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma. Issue 8 (6th February 2022) Authors: Cantor, Evan; Wierzbicki, Kyle; Tarapore, Rohinton S; Ravi, Karthik; Thomas, Chase; Cartaxo, Rodrigo; Nand Yadav, Viveka; Ravindran, Ramya; Bruzek, Amy K; Wadden, Jack; John, Vishal; May Babila, Clarissa; Cummings, Jessica R; Rahman Kawakibi, Abed; Ji, Sunjong; Ramos, Johanna; Paul, Alyssa; Walli... Journal: Neuro-oncology Issue: Volume 24:Issue 8(2022) Page Start: 1366 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗